Teen girls less successful than boys at quitting meth, pilot study says

A UCLA-led study of adolescents receiving treatment for methamphetamine dependence has found that girls are more likely to continue using the drug during treatment than boys, suggesting that new approaches are needed for treating meth abuse among teen girls.

Results from the study, conducted by the UCLA Center for Behavioral and Addiction Medicine and the community-based program Behavioral Health Services Inc., are published in the April edition of the Journal of Adolescent Health.

"The greater severity of methamphetamine problems in compared to boys, combined with results of studies in adults that also found women to be more susceptible to methamphetamine than men, suggests that the in methamphetamine addiction observed in adults may actually begin in adolescence," said the study's lead author, Dr. Keith Heinzerling, a health sciences assistant clinical professor of at the David Geffen School of Medicine at UCLA.

The clinical trial focused on use of the antidepressant bupropion for treating methamphetamine addiction. Nineteen adolescents—nine boys and 10 girls—with meth addiction who were receiving counseling at Behavioral Health Services were given either bupropion or placebo pills. The average age of participants was approximately 17.5 years.

The researchers found that the study subjects who received the antidepressant provided significantly fewer meth-free urine samples than did those who were given placebos, suggesting that bupropion was an ineffective treatment for addiction in this small sample.

Overall, boys in both groups provided more than twice as many meth-free urine drug tests during treatment as girls in both groups.

While the results did not support continued research into the use of bupropion for addiction, they did suggest the need for research to develop new interventions to improve the outcomes of treatment for addiction in adolescent girls, the researchers said.

Heinzerling noted the importance of collaborations such as the one between UCLA and Behavioral Health Services.

"It shows that partnerships between researchers and community organizations are critical to insuring that research is translated into improvements in the health of real people," he said.

Related Stories

Toward a vaccine for methamphetamine abuse

date May 11, 2011

Scientists are reporting development of three promising formulations that could be used in a vaccine to treat methamphetamine addiction — one of the most serious drug abuse problems in the U.S. The report ...

Meds can help recovering meth addicts stay sober

date Jun 14, 2012

(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has ...

Recommended for you

Smokers who use e-cigarettes less likely to quit

date Apr 16, 2015

The rapid increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation tool. A study, published ...

Evidence that synthetic drugs can cause cancer

date Apr 16, 2015

Almost weekly, a new synthetic psychoactive drug comes onto the market somewhere in Europe that can be ordered legally and easily, for example as an incense blend, via the Internet. Synthetic cannabinoids ...

Benefits of heroin treatment for drug users

date Apr 14, 2015

Drug users who do not benefit from conventional treatments for heroin addiction should be able to access the drug through the health system, urges a Canadian expert in The BMJ today.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.